NCT06180577View on ClinicalTrials.gov

A Survey Study to Assess the Accessibility of the Nerivio Device At School

CompletedOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

May 1, 2024

Study Completion Date

May 15, 2024

Conditions
Migraine in Children
Interventions
DEVICE

Nerivio

Nerivio is a prescribed Remote Electrical Neuromodulation (REN) device for treatment of migraine

Trial Locations (1)

08807

Theranica USA Inc, Bridgewater

Sponsors

Lead Sponsor

Theranica
All Listed Sponsors
lead

Theranica

INDUSTRY

NCT06180577 - A Survey Study to Assess the Accessibility of the Nerivio Device At School | Biotech Hunter | Biotech Hunter